Birchview Capital as of Sept. 30, 2019
Portfolio Holdings for Birchview Capital
Birchview Capital holds 50 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 46.3 | $70M | 700k | 99.30 | |
| Accelr8 Technology | 27.0 | $41M | 2.2M | 18.57 | |
| Neurocrine Biosciences (NBIX) | 3.3 | $5.0M | 55k | 90.11 | |
| Eqt Midstream Partners | 2.2 | $3.3M | 101k | 32.70 | |
| Quidel Corporation | 2.0 | $3.0M | 49k | 61.36 | |
| Oxford Immunotec Global | 1.9 | $2.8M | 170k | 16.63 | |
| Bristol Myers Squibb (BMY) | 1.6 | $2.4M | 47k | 50.70 | |
| Vermillion | 1.1 | $1.7M | 3.2M | 0.52 | |
| Dova Pharmaceuticals | 0.9 | $1.4M | 50k | 27.96 | |
| Masimo Corporation (MASI) | 0.8 | $1.2M | 8.0k | 148.75 | |
| Biogen Idec (BIIB) | 0.8 | $1.2M | 5.0k | 232.80 | |
| Vanda Pharmaceuticals (VNDA) | 0.7 | $1.1M | 80k | 13.28 | |
| Arena Pharmaceuticals | 0.7 | $1.0M | 22k | 45.77 | |
| Harrow Health (HROW) | 0.7 | $1.0M | 180k | 5.62 | |
| G1 Therapeutics | 0.6 | $911k | 40k | 22.78 | |
| Amarin Corporation | 0.6 | $894k | 59k | 15.15 | |
| Myriad Genetics (MYGN) | 0.6 | $859k | 30k | 28.63 | |
| Dermira | 0.5 | $767k | 120k | 6.39 | |
| Albireo Pharma | 0.5 | $760k | 38k | 20.00 | |
| Acceleron Pharma | 0.5 | $738k | 19k | 39.52 | |
| Corcept Therapeutics Incorporated (CORT) | 0.5 | $707k | 50k | 14.14 | |
| Karyopharm Therapeutics | 0.5 | $673k | 70k | 9.61 | |
| Arvinas Ord (ARVN) | 0.4 | $647k | 30k | 21.57 | |
| Wright Medical | 0.4 | $619k | 30k | 20.63 | |
| Dicerna Pharmaceuticals | 0.4 | $574k | 40k | 14.35 | |
| Intercept Pharmaceuticals In | 0.4 | $551k | 8.3k | 66.39 | |
| Odonate Therapeutics Ord | 0.3 | $521k | 20k | 26.05 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $504k | 14k | 36.00 | |
| Voyager Therapeutics (VYGR) | 0.3 | $516k | 30k | 17.20 | |
| Pioneer Natural Resources | 0.3 | $478k | 3.8k | 125.79 | |
| ImmunoGen | 0.3 | $436k | 180k | 2.42 | |
| Xencor (XNCR) | 0.3 | $415k | 12k | 33.74 | |
| Veracyte (VCYT) | 0.2 | $378k | 16k | 23.97 | |
| Soleno Therapeutics | 0.2 | $361k | 241k | 1.50 | |
| Kalvista Pharmaceuticals (KALV) | 0.2 | $348k | 30k | 11.60 | |
| Xbiotech (XBIT) | 0.2 | $314k | 30k | 10.47 | |
| Amicus Therapeutics (FOLD) | 0.2 | $305k | 38k | 8.03 | |
| Sientra | 0.2 | $259k | 40k | 6.48 | |
| Continental Resources | 0.2 | $246k | 8.0k | 30.75 | |
| Lexicon Pharmaceuticals (LXRX) | 0.2 | $241k | 80k | 3.01 | |
| Encana Corp | 0.1 | $228k | 50k | 4.60 | |
| Mereo Biopharma Group Plc ads (MREO) | 0.1 | $231k | 78k | 2.98 | |
| Cytokinetics (CYTK) | 0.1 | $114k | 10k | 11.40 | |
| Tg Therapeutics (TGTX) | 0.1 | $84k | 15k | 5.60 | |
| Workhorse Group Inc ordinary shares | 0.1 | $88k | 25k | 3.52 | |
| Contrafect | 0.1 | $82k | 227k | 0.36 | |
| BioCryst Pharmaceuticals (BCRX) | 0.0 | $57k | 20k | 2.85 | |
| Yield10 Bioscience | 0.0 | $62k | 124k | 0.50 | |
| Livent Corp | 0.0 | $67k | 10k | 6.70 | |
| Aevi Genomic | 0.0 | $19k | 128k | 0.15 |
